PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Approved indications for DBS therapy • History of DBS PART 05: Potential applications of DBS PART 06: Cost of DBS system components and implantation PART 07: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 08: Market segmentation by application • PD • Dystonia • OCD • Epilepsy PART 09: Geographical segmentation • DBS market in Americas • DBS market in EMEA • DBS market in APAC PART 10: Market drivers • Increase in prevalence of neurological disorders • Availability of funds and grants for R&D • Increased number of market approvals PART 11: Impact of drivers PART 12: Market challenges • High cost of DBS therapy • Complications related to DBS • High maintenance and low battery lifetime PART 13: Impact of drivers and challenges PART 14: Market trends • Hybrid neuroprosthetic devices • Next-generation therapies for nervous system disorders • Emergence of clinician programmer PART 15: Vendor landscape • Competitive scenario • Market share analysis PART 16: Key vendor analysis • Boston Scientific • Medtronic • St. Jude Medical • Other prominent vendors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio   List of Exhibits Exhibit 01: Product offerings Exhibit 02: Neurological conditions and their symptoms treated by DBS therapy Exhibit 03: History of DBS Exhibit 04: Conditions under investigation for DBS therapy Exhibit 05: Cost of DBS implantation and treatment Exhibit 06: Cost difference between DBS and pharmacological and follow-up cost 2015 Exhibit 07: Cost breakdown of DBS components 2015 Exhibit 08: Cost breakdown of pharmacological and follow-up cost in DBS 2015 Exhibit 09: Adverse event cost (due to surgical error) of DBS implantation 2015 Exhibit 10: Global DBS market by revenue 2015-2020 ($ millions) Exhibit 11: Five forces analysis Exhibit 12: Global DBS market segmentation by application 2015 Exhibit 13: Global DBS market by application 2015 Exhibit 14: Global DBS market by geography 2015 Exhibit 15: Global DBS market by geography 2020 Exhibit 16: Conditions treated by DBS in the US Exhibit 17: Economic burden of diseases in the US Exhibit 18: DBS market in Americas 2015-2020 ($ millions) Exhibit 19: Prevalence and financial burden of neurodegenerative diseases in Europe 2010 Exhibit 20: DBS market in EMEA 2015-2020 ($ millions) Exhibit 21: DBS market in APAC 2015-2020 ($ millions) Exhibit 22: Global DBS market by geography 2015-2020 Exhibit 23: Global DBS market by geography 2015-2020 ($ millions) Exhibit 24: Research funding for DBS Exhibit 25: Regulatory approvals for DBS System Exhibit 26: Impact of drivers Exhibit 27: Impact of drivers and challenges Exhibit 28: Boston Scientific: Product portfolio Exhibit 29: Boston Scientific: Neuromodulation segment by revenue 2012-2014 ($ millions) Exhibit 30: Boston Scientific: Key takeaways Exhibit 31: Medtronic: Product portfolio Exhibit 32: Medtronic: Neuromodulation segment by revenue 2013-2015 ($ billions) Exhibit 33: Medtronic: Key takeaways Exhibit 34: St. Jude Medical: Product portfolio Exhibit 35: St. Jude Medical: Neuromodulation segment by revenue 2012-2014 ($ millions) Exhibit 36: St. Jude Medical: Key takeaways

Boston Scientific Corp., Medtronic plc, St. Jude Medical Inc, Adaptive Neuromodulation, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace, NeuroSigma.